or promissory note and specify the date of March 3rd, 2022 as the due date for payment of principal Other Conditions : None Objectives : To be used for capital expenditure of the Company and to be

2.0 million sq.ft /month Table 7: Capital Expenditure 1Q2017 Bt268.7 million 2Q2017 Bt233.7 million An additional investment in Phase 3 of the new plant was made in the second quarter of 2017, which

4Q2017 1.7 million sq.ft / month 2Q2018 2.0 million sq.ft /month Table 7: Capital Expenditure 1Q2017 Bt 268.7 million 2Q2017 Bt 233.7 million 3Q2017 Bt 305.4 million An additional investment in Phase 3 of

) Total revenue 172.32 Expenditure 167.18 Net profit (loss) 5.14 Earning per share (baht) 0.60 Book value per share (baht) 0 Weight common stock (share) 8,636,100.00 10. Opinion of the company(s audit

’ Equity 8,596.43 8,725.88 Total Revenue 4,230.54 7,295.79 Expenditure 3,895.06 6,720.06 Net Profit (Loss) 230.13 366.68 Earning Per Share (E.P.S.) 0.273 0.41 Book value per share (baht) 10.12 10.28 Weighted

, resulting in the increase of selling expenses comparing to 1H18 in which we did not have these expenditure. In addition, there are also expenses of sales promotion, booth exhibition, cost of samples, and

, higher repair and maintenance expenditure of medical equipment, and higher depreciation and amortization expenses resulted from the expansions of a new hospital and new specialized centers in the existing

liability 4,470 Registered and paid up capital 1,655 Shareholders’ equity 6,047 Total revenue 3,853 Expenditure 3,075 Net profit (loss) 683 Earning per share (baht) 3.94 Book value per share (baht) 36.54

them of clear and specific objectives as well as their rights, namely right to access data, right to rectification, right to restrict data processing, and right to be forgotten. 2. Proper technology must

TRIPPLE LIFT SERUM 2. SOS HYALURON X3 CONCENTRATE SERUM 3. SOS HYALURON & COLLAGEN FREEZE-DRIED MASK 4. OXE’CURE ACNE CLEAR POTION 5. OXE'CURE ACNE CLEAR POWDER MUD 6. OXE’CURE ACNE CLEAR POWDER LOTION 7